-
Boeing Analyst Says 737 Max Production Halt A 'Nuclear Option'
Monday, December 16, 2019 - 3:39pm | 539Read More...Aircraft maker Boeing Co (NYSE: BA) could be hours away from confirming that it will halt or cut back production of the 737 MAX aircraft. This would be consistent with the company's recent track record of setting expectations and then missing them, according to one analyst. Boeing...
-
Analysts Furnish Portfolios With RH After Beat-And-Raise Quarter
Thursday, December 5, 2019 - 12:01pm | 764Read More...Restoration Hardware Holdings (NYSE: RH) surged Thursday after reporting its third consecutive bottom-line beat and raise. “To management’s credit, this is becoming a common theme, as earnings have surprised to the upside multiple times this year,” Raymond James analysts...
-
Analysts Offer Positive Prognosis For UnitedHealth After Investor Day
Wednesday, December 4, 2019 - 1:10pm | 638Read More...UnitedHealth Group Inc (NYSE: UNH) plummeted ahead of Tuesday’s investor day and failed to recover throughout the session. However, analysts walked away from the presentation more bullish on the stock. “The investor day reinforced our thesis that we believe EPS visibility is high for...
-
Best Buy Soars On Q3 Earnings Beat, But Tariffs Remain A Concern
Wednesday, November 27, 2019 - 12:55pm | 761Read More...Best Buy Co Inc (NYSE: BBY) shares hit a 52-week high Tuesday after reporting a third-quarter earnings beat. Tariffs At Front Of Mind For Best Buy Analysts High-quality growth is priced into Best Buy shares, as investors are “increasingly willing to pay a premium” for the...
-
Brace For Stricter FDA Regulation Of CBD Consumer Products, Analysts Say
Tuesday, November 26, 2019 - 5:45pm | 490Read More...Cannabis stocks headed lower Tuesday after a Monday communication from the FDA, which sent warning letters to 13 companies for illegally selling products containing containing cannabidiol (CBD), violating the Federal Food, Drug, and Cosmetic Act. The 15 companies were warned for...
-
Analysts React To Gap's Q3 Earnings Beat, Target Taking Market Share From Old Navy
Friday, November 22, 2019 - 4:34pm | 735Read More...Gap Inc (NYSE: GPS) shares are moving higher one day after reporting a third-quarter earnings beat, despite seeing all three of its main segments deliver negative comps. Wells Fargo With Gap’s third-quarter outlook and CEO departure pre-announced earlier in the month, analyst Ike...
-
'Worst Looks Over' For Canopy Growth, Bank Of America Says In Upgrade
Wednesday, November 20, 2019 - 11:57am | 388Read More...Canopy Growth Corp's (NYSE: CGC) shares have fallen 65% in the last six months. On Wednesday, the cannabis stock received an upgrade from Bank of America Merrill Lynch, which said Canopy is poised to meet Street expectations. The Analyst Christopher Carey upgraded Canopy Growth from...
-
Canopy Growth Analysts Lower Price Targets After Q2 Report
Friday, November 15, 2019 - 5:28pm | 760Read More...Over the last 12 months, Canopy Growth Corp (NYSE: CGC) (TSE: WEED) shares have fallen 55%. The cannabis company reported second-quarter results Thursday, posting net revenue of CA$76.6 million ($84.2 million) and a net loss of CA$374.6 million. The Analysts Bank of America Merrill...
-
Bank Of America Upgrades BioCryst As Financing Overhang Lifts Partially
Friday, November 15, 2019 - 2:38pm | 276Read More...BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) completed a $55 million equity raise earlier this week. While further financing may be needed to make the company launch ready, the recent equity raise has provided “some cushion,” according to Bank of America. The Analyst BofA’s...
-
Roku Analyst Breaks Down What Black Friday Deals Mean For The Stock
Friday, November 15, 2019 - 12:34pm | 369Read More...Roku Inc (NASDAQ: ROKU) has released its lineup of Black Friday sales and deals, creating the potential for strong fourth-quarter account additions, according to Bank of America Merrill Lynch. The Analyst Ziv Israel maintained a Buy rating on Roku with a price target lifted from $150 to...
-
Canopy Growth Analysts Parse Q2 Print As Investors Retreat
Thursday, November 14, 2019 - 3:02pm | 503Read More...Over the last six months, Canopy Growth Corp (NYSE: CGC) shares have fallen 65.45%. The company released second-quarter results Thursday that sent the stock lower. The Analysts Bank of America Merrill Lynch’s Christopher Carey reiterated a Neutral rating on Canopy...
-
2 Takes On SmileDirectClub's First Quarterly Print As Public Company
Wednesday, November 13, 2019 - 3:55pm | 471Read More...SmileDirectClub Inc (NASDAQ: SDC) reported third-quarter results Tuesday that were "good enough" in one Street analyst's view, while another found fault in management's fourth-quarter outlook. The Analysts Bank of America Merrill Lynch analyst Michael Ryskin maintained a Buy...
-
Analyst Trims NextCure Price Target Following SITC Presentation, Still Sees Big Upside
Tuesday, November 12, 2019 - 4:25pm | 368Read More...NextCure Inc (NASDAQ: NXTC) shares are settling down after the volatile run in the past few sessions. With the Society for Immunotherapy of Cancer presentation and the third-quarter earnings now past, an analyst at Bank of America reviewed the events but deemed it fit to hold on to his bullish...
-
BofA: Cronos Group Has Potential To Be Long-Term Cannabis Leader
Tuesday, November 12, 2019 - 4:16pm | 446Read More...Over the last six months, Cronos Group Inc. (NASDAQ: CRON) shares have fallen by 43.3%. The Analyst Bank of America Merrill Lynch’s Christopher Carey maintained a Buy rating on Cronos Group with a $13 price objective. The Thesis BofA's price objective for Cronos is based...
-
Analyst: Canopy Growth Looks Greener Than It Did 6 Weeks Ago
Wednesday, November 6, 2019 - 11:48am | 357Read More...Over the past 12 months, Canopy Growth’s (NYSE: CGC) shares have fallen by half. The Analyst Bank of America Merrill Lynch’s Christopher Carey reiterated a Neutral rating on Canopy Growth with a $23 price objective. The Thesis The risk-reward profile for Canopy's second-...
